Companies /Healthcare

Biogen Inc

NASDAQ: BIIB Drug Manufacturers - General
$244.05
▼ $8.68 (−3.43%) today
Markets closed · 4:57am ET

BIIB Coverage Page 24

8:35am ET
Health and Healthcare

3 Potential Huge Takeover Targets in Biotech

In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.

Lee Jackson
7:57am ET
Health and Healthcare

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…

Chris Lange